Chentai New Materials
Chentai New Materials is a Suzhou-based Chinese manufacturer of ZTA and TZP biomedical ceramic components — femoral heads, inserts, and related orthopedic, dental, and veterinary implant parts — sold directly B2B to medical device manufacturers as a domestic alternative to imported German ceramic materials.
- Company typePrivate
- Founded2020
- HeadquartersSuzhou, China
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Chentai New Materials does
Chentai New Materials (Suzhou TrendTec New Materials Technology Co., Ltd.; 苏州宸泰新材料科技有限公司) is a privately held Chinese specialty materials manufacturer founded in 2020 that designs, develops, manufactures, and sells high-performance biomedical ceramic components for orthopedic and dental implant applications. The company's core products are Zirconia Toughened Alumina (ZTA) ceramic femoral heads and inserts and Tetragonal Zirconia Polycrystal (TZP) ceramic femoral heads, used by medical device manufacturers in ceramic-on-ceramic hip joint replacement systems; the portfolio also includes ceramic shoulder, TKA (total knee arthroplasty), UKA (unicondylar knee arthroplasty) components, two-piece and one-piece ceramic dental implants, and veterinary ceramic ball heads. The company is positioned to address a structural "bottleneck" in China's orthopedic industry, where 100% of ceramic femoral heads and inserts for both imported and domestic hip implants have historically been supplied by a single foreign (German) manufacturer controlling roughly 95% of global market share.
The company operates from a single headquarters in Suzhou High-tech Zone Science and Technology City within the Jiangsu Medical Device Science and Technology Industrial Park, comprising more than 8,000 square meters of modern precision manufacturing space including a 100,000-class cleanroom, with annual production capacity of 300,000 ceramic components (expandable to 600,000 units). Its full-process manufacturing stack — powder preparation, sintering, hot isostatic pressing, precision machining, nano-level polishing, and 100% inspection — is protected by more than 30 pieces of independent intellectual property and certified to ISO 9001 and ISO 13485 quality management standards, with ZTA products tested under ISO 6474-2 and ISO 10993 and TZP products tested under ISO 13356 and ISO 10993. The company was selected in July 2023 for the first batch of the MIIT/NMPA biomedical material "Bounty Challenge" (揭榜挂帅) program and completed NMPA master file registration (M2024246-000 and M2024277-000) in August 2024, becoming one of the first domestic Chinese material manufacturers to do so.
Chentai generates revenue through direct B2B sales of finished ceramic components and ceramic raw materials to orthopedic, dental, and veterinary implant manufacturers, with quote-based pricing stated at less than 50% of comparable imported German products. The company employs an enterprise field sales motion anchored by participation in the annual Chinese Orthopaedic Association (COA) congresses in Xi'an (2023), Wuhan (2024), and Tianjin (2025), supplemented by an event-driven marketing approach, government-recognized innovation competitions, and bilingual corporate website content. It has raised over RMB 100 million in a December 2024 Series A led by Vivo Capital with CICC Capital, followed by tens of millions of RMB in a January 2025 Series B from Perillastars Venture Capital and Zhongxin Capital, with use of funds directed at production line construction and iterative product R&D.
Chentai New Materials firmographics
Firmographics- Name
- Chentai New Materials
- Legal name
- 苏州宸泰新材料科技有限公司
- Website
- https://trendtec.cn
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Short description
- Chentai New Materials is a Suzhou-based Chinese manufacturer of ZTA and TZP biomedical ceramic components — femoral heads, inserts, and related orthopedic, dental, and veterinary implant parts — sold directly B2B to medical device manufacturers as a domestic alternative to imported German ceramic materials.
- Ownership category
- akta.pro rank
Chentai New Materials industry classification
Industry- Product category
- Orthopedic Biomaterials
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Dental Equipment and Supplies Manufacturing (339114)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Dental Equipment & Supplies (3843)
- akta.pro primary industry
- Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
- akta.pro secondary industries
- Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics) (HLAHAEAE), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)
Keywords
Where Chentai New Materials is headquartered
LocationHeadquarters
- HQ city
- Suzhou
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
Chentai New Materials business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Supply Chain, Personnel, Infrastructure, Marketing or Sales
Revenue model
- Biomedical Ceramic Components and Materials Sales: Direct B2B sales of ZTA and TZP ceramic femoral heads, inserts, and other orthopedic ceramic components to medical device manufacturers (hip, knee, shoulder, dental implant companies). Revenue is generated through the sale of finished ceramic components and ceramic raw materials for use in downstream medical device manufacturing.
- Medical Device Raw Material Supply: Supply of ZTA ceramic materials to orthopedic device manufacturers. As one of the first domestic companies to complete master file (主文档) registration with China's NMPA, the company provides its ceramic materials to downstream device makers who reference the master file in their own product registrations. Pricing is significantly lower than imported alternatives.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B pricing for ceramic femoral heads and inserts (ZTA/TZP materials) |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Chentai New Materials product offering
Product offeringCore offering
Chentai New Materials designs, develops, manufactures, and sells high-performance biomedical ceramic materials and components for orthopedic and dental implant applications. Its core products are Zirconia Toughened Alumina (ZTA) and Tetragonal Zirconia Polycrystal (TZP) ceramic femoral heads, inserts/liners, and related hip, knee, shoulder, and dental implant components, which it sells directly as sub-components and raw materials to medical device manufacturers in China and internationally.
Differentiator
Problem solved
Functional benefit
Brands
- TOUMIC®: Registered trademark of TrendTec New Materials, used for biomedical ceramic products.
- CLEAMIC®
Products and services
- ZTA Ceramic Femoral Heads Oxide zirconia toughened alumina (ZTA) composite ceramic femoral heads (ball heads) used in artificial hip joint replacement. Combines high hardness and wear resistance of alumina with improved fracture toughness of zirconia, designed for hard-on-soft and ceramic-on-ceramic bearing surfaces. Sold as a critical sub-component to orthopedic implant manufacturers.
- ZTA Ceramic Inserts (Liners) ZTA ceramic acetabular inserts/liners used in hip replacement systems, paired with ZTA or TZP femoral heads for ceramic-on-ceramic hip bearings. Designed for orthopedic implant manufacturers for use in total hip arthroplasty (THA) systems.
- TZP Ceramic Femoral Heads High-purity Tetragonal Zirconia Polycrystal (TZP) ceramic femoral heads with very high flexural strength (1,800 MPa) and fracture toughness (10.5 MPa·m1/2) for hip joint replacement. Compliant with ISO 13356 mechanical and ISO 10993 biocompatibility requirements. Sold to orthopedic implant manufacturers.
- ZTA Ceramic Hip Joint Components Complete ZTA ceramic hip joint component sets (femoral heads and inserts) intended for use with femoral stems and acetabular cups to replace diseased hip joint components. Compliant with ISO 6474-2 mechanical tests and ISO 10993 biocompatibility. Sold to medical device manufacturers for incorporation into finished hip implant systems.
- Ceramic Knee Joint Components (TKA and UKA) Ceramic components for Total Knee Arthroplasty (TKA) and Unicondylar Knee Arthroplasty (UKA), including ceramic unicondylar (单髁) components. Leverages ZTA/TZP strength and fracture toughness to enable complex-shaped components for knee replacement. Sold to orthopedic knee implant manufacturers.
- Ceramic Shoulder Joint Components Specialized ZTA/TZP ceramic components for shoulder replacement implants, leveraging high strength and fracture toughness to enable complex shapes not possible with traditional materials. Sold to orthopedic shoulder implant manufacturers.
- ZTA Ceramic Dental Implants (Two-Piece and One-Piece) Two-piece and one-piece ceramic dental implants utilizing ZTA material, designed to reduce peri-implantitis incidence and enhance aesthetic outcomes. Ceramic surface reduces biofilm formation and metal ion release compared to traditional titanium implants. Sold to dental implant manufacturers.
- Veterinary Ceramic Femoral Heads (Animal Ceramic Ball Heads) Ceramic ball heads for animal (veterinary) hip replacement applications used in treating animal hip dislocation. High-biocompatibility ceramic suitable for veterinary applications at various animal sizes. Sold to veterinary implant manufacturers.
- Ceramic Dual Mobility Total Hip Components Ceramic dual mobility total hip arthroplasty (DM-THA) components leveraging ZTA ceramic materials. Designed for hip replacement systems requiring enhanced range of motion and stability. Sold to orthopedic hip implant manufacturers.
- Ceramic Surface Hip Joint Components (Cone-Sleeve Ceramic Heads) Ceramic surface hip joint components including cone-sleeve ceramic heads (带锥套陶瓷球头) for ceramic-on-ceramic hip resurfacing applications. Sold to orthopedic implant manufacturers.
Quantifiable outcome
- Price is less than 50% of comparable imported German ceramic femoral heads and inserts
- +5 more outcomes
Companies that use Chentai New Materials
Customer profileSegments3 records
Ideal customer profiles3 records
Chentai New Materials technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Chentai New Materials partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and core.
- Ministry of Industry and Information Technology of China (MIIT) / National Medical Products Administration (NMPA)flagshipChentai New Materials was officially selected as a recipient of the first batch '揭榜挂帅' (Bounty Challenge) program jointly issued by China's Ministry of Industry and Information Technology and the National Medical Products Administration in 2023. The program tasked Chentai with developing ZTA (zirconia toughened alumina) ceramic femoral heads and inserts to address critical import dependency ('bottleneck') in biomedical materials for artificial joints. This represents a nationally recognized strategic mandate for technology development and import substitution.
- National Technical Committee for Surgical Implants and Orthopedic Devices (SAC/TC110) — Implant Ceramic Materials Working Group (WG3)coreCompany founders Zhang Lin (张琳博士) and Cao Xiaogang (曹小刚博士) serve as members of the National Technical Committee for Surgical Implants and Orthopedic Devices (SAC/TC110) Working Group 3, which is responsible for formulating industry standards for implant ceramic materials in China. This role gives the company influence over national standards development and deepens its regulatory and industry relationships.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
Chentai New Materials competitors and assessment
Company assessmentBroad incumbents
- CeramTec (CeramTec Group): German global leader in ceramic femoral heads and inserts with ~95% global market share, currently the sole supplier (100%) of ceramic hip joint components used in China. Direct incumbent that Chentai is explicitly positioned to displace on cost and localization grounds.
Direct peers
- AK Medical (爱康医疗): Leading Chinese orthopedic implant manufacturer (hip and knee) and a likely Chentai customer. Comparable because it is both a domestic competitor in the broader orthopedic space and a primary design-in target for Chentai's ceramic components.
- Shanghai MicroPort Orthopedics (微创骨科): Chinese orthopedic implant business under MicroPort Scientific, manufacturing hip and knee prostheses. Comparable as both a domestic orthopedic peer and a high-value potential customer seeking localized ceramic components.
- Chunli Zhengdao Medical (春立正达): Major Chinese orthopedic implant manufacturer with hip and knee product lines. Comparable as a domestic orthopedic peer and a likely customer for Chentai's ceramic femoral heads and inserts.
Regional players
- LDK Medical (力达康 / Lidakang): Chinese orthopedic joint replacement manufacturer focused on hip and knee implants. Comparable as a domestic OEM target for Chentai's ceramic components and as a regional player in the same Chinese orthopedic value chain.
Emerging players
- Waldemar Link (Link Orthopedics): German orthopedic implant manufacturer with partial ceramic hip and knee product lines. Comparable as an international competitor with its own ceramic component development, providing an alternative to the CeramTec supply monopoly.
- Doceram Medical Ceramics: German specialist in technical ceramics with a medical division producing ceramic components for orthopedic applications. Comparable as a Europe-based materials/component peer in the same ceramic orthopedic supply market.
- Straumann (dental implants): Global leader in dental implants, including ceramic (zirconia) implant systems that compete with Chentai's two-piece and one-piece ceramic dental implant offerings. Comparable as a downstream dental implant peer with overlapping ceramic implant technology.
- Nobel Biocare: Global dental implant company with ceramic (zirconia) implant product lines such as N1 and Pure Ceramic. Comparable as a peer in ceramic dental implants — an adjacent indication Chentai is also pursuing.
Others
- Sagemax (Zirconia block and disc supplier): Global supplier of zirconia materials for dental and medical applications, including orthopedic ceramics. Comparable as an upstream materials peer in the same biomedical ceramic value chain, though focused on dental rather than orthopedic implants.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Chentai New Materials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Chentai New Materials leadership team
Management profileNumber of profiles
Profiles2 records
Chentai New Materials funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Chentai New Materials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Chentai New Materials
What does Chentai New Materials do?
Chentai New Materials designs, develops, manufactures, and sells high-performance biomedical ceramic materials and components for orthopedic and dental implant applications. Its core products are Zirconia Toughened Alumina (ZTA) and Tetragonal Zirconia Polycrystal (TZP) ceramic femoral heads, inserts/liners, and related hip, knee, shoulder, and dental implant components, which it sells directly as sub-components and raw materials to medical device manufacturers in China and internationally.
Is Chentai New Materials a public or private company?
Chentai New Materials is a private company. It is classified as venture growth investor backed and is currently operating.
When was Chentai New Materials founded?
Chentai New Materials was founded in 2020.
Where is Chentai New Materials based?
Chentai New Materials is headquartered in Suzhou, China, in the Asia region.
How does Chentai New Materials make money?
Two revenue lines are on record. Biomedical Ceramic Components and Materials Sales are the primary driver. The others are medical Device Raw Material Supply.
Who are Chentai New Materials's main competitors?
CeramTec (CeramTec Group) is listed as a broad incumbent. Direct peers are AK Medical (爱康医疗), Shanghai MicroPort Orthopedics (微创骨科) and Chunli Zhengdao Medical (春立正达). LDK Medical (力达康 / Lidakang) is listed as a regional player. Emerging players are Waldemar Link (Link Orthopedics), Doceram Medical Ceramics, Straumann (dental implants) and Nobel Biocare. Sagemax (Zirconia block and disc supplier) is listed as an others.
Does Chentai New Materials have an API?
No public API is recorded for Chentai New Materials.
What industry is Chentai New Materials in?
Chentai New Materials's product category is Orthopedic Biomaterials. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAE, Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics). Its NAICS code is 339113 and its SIC code is 3842.